Skin Disease More Recalcitrant to Intervention Than Muscle Disease: A Long-Term Prospective Study of 184 Children with Juvenile Dermatomyositis Andi Wang, BA – Northwestern University Feinberg School of Medicine
11:10 AM – 11:20 AM ET
NXP2 Autoantibodies Link to Interferon Signature in Juvenile Myositis Lesional Skin Jessica L. Turnier, MD – University of Michigan
11:20 AM – 11:30 AM ET
Janus Kinase (JAK) Inhibition with Baricitinib in Refractory Juvenile Dermatomyositis Hanna Kim, MD, MS – National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
11:30 AM – 11:40 AM ET
Abatacept Treatment Reduces Cutaneous and Joint Activity in Juvenile Localized Scleroderma Suzanne Li, MD, PhD – Hackensack Meridian School of Medicine
11:40 AM – 11:50 AM ET
Longitudinal Evaluation of Axonal Dysfunction, Neuronal Markers and Serum Cytokines in Childhood-onset Systemic Lupus Erythematosus Simone Appenzeller, MD, PhD – Unicamp
.png "Fatma Dedeoglu, MD photo")
